ISSCR News
The ISSCR Signs Two Letters Opposing U.S. Administration’s Immigration Policies
Letters Cite Detrimental Affects to Scientific Advancement and Global Competitiveness
The ISSCR joined scientific societies in a joint letter to The White House and U.S. Administration officials citing grave concerns that the latest proposed Immigration and Customs Enforcement (ICE) action will cost the U.S. the current cohort of future innovators now enrolled in U.S. schools. The letter goes on to say the policy change could permanently destroy one of America’s main competitive advantages…
Member Spotlight: Stephanie Protze, PhD
“I think the most rewarding aspect of the work that we all do in the stem cell field is the potential to move our discoveries into the clinic and improve the life of patients one day. Knowing this gives me a lot of motivation”.
ISSCR Urges FDA and EMA to Enforce Regulation of Clinics Offering Unproven and Unapproved Stem Cell-based Interventions
Misleading Marketing Preys on the Hopes of Patients and Families, Including Those with COVID-19
Skokie, IL – In letters released today by the International Society for Stem Cell Research (ISSCR) to the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), the Society presses for greater enforcement to help protect patients suffering from devastating diseases including COVID-19.
Member Spotlight: Fiona Watt, PhD
“I am studying the stem cells of human epidermis, focusing on how cells exit from the stem cell compartment. What is most rewarding at present is validating our experimental observations using single cell RNA seq data from the Human Cell Atlas”.
ISSCR Shares Recommendations for Proposed Genome Editing Registry with WHO
In a letter to Justice Edwin Cameron and Margaret Ann Hamburg, Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing, World Health Organization (WHO), the ISSCR shared its recommendations regarding plans to create a genome editing registry. The recommendations are intended to help to ensure that the proposed registry attracts legitimate submissions of fundamental and preclinical research and avoid abuse by businesses seeking to prematurely commercialize genome editing technologies.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .